In the presence of the German Ambassador and the Chairman of EDB Singapore, 
Syntellix Asia Pte Ltd inaugurates its production site in Tuas, which hosts the 
first dry CNC processing of such advanced magnesium alloys in Asia. Thus, 
Singapore becomes the Asian hub for the globally unique bioabsorbable metallic 
implants developed by German med-tech pioneer Syntellix AG that can save many 
lives by making obsolete implant removal surgeries and their associated 
infection and anesthesia risks.

Photo - https://photos.prnasia.com/prnh/20190910/2575284-1 

Syntellix was honoured in May with the German Innovation Award in Gold for its 
MAGNEZIX(R) Pins magnesium implants. MAGNEZIX(R) implants degrade in the human 
body, and are converted into bone tissue, thus supporting the healing process. 
Gowreeson Thevendran, a leading surgeon from Singapore, described the magnesium 
technology developed by Syntellix as "the new gold standard" for orthopaedic 
and trauma surgery, because in his profound experience at Tan Tock Seng 
Hospital, Mount Elizabeth Novena, and Raffles Hospital, they have no 
disadvantages, but many advantages compared with conventional implants made 
from titanium. Syntellix implants have also been successfully used at NUH, SGH, 
CGH, Gleneagles, Mount Elizabeth Orchard, Farrer Park Hospital and Sengkang 
General Hospital. They have product registration in 56 countries worldwide 
including Singapore.

"This is a very proud day for us, and a very good day for Singapore and its 
fantastic population," said Prof Dr Utz Claassen, CEO of Syntellix AG and 
Executive Chairman of Syntellix Asia Pte Ltd, at the inauguration ceremony. "We 
see it as a further confirmation that our unique magnesium technology has the 
potential to replace conventional titanium, steel or polymer implants 
everywhere in the world. Today's milestone will therefore be an added incentive 
for us to uncompromisingly pursue our winning approach for the good of patients 
around the globe."

"Syntellix's decision to establish its production site in Singapore is a vote 
of confidence in Singapore's strength as a location for advanced and high tech 
manufacturing activities. Syntellix's MAGNEZIX orthopaedic implant system is 
highly innovative and we look forward to the new facility here contributing to 
its commercial success." said Dr Beh Swan Gin, Chairman of EDB.

Syntellix Asia Pte Ltd is a 100% subsidiary of Syntellix AG, Hannover/Germany. 
Syntellix is the world market and technology leader in the field of 
bioabsorbable metallic orthopaedic implants.

SOURCE: Syntellix Asia Pte Ltd